Navigation Links
EAG Announces New General Manager of Release-To-Production (RTP) Division
Date:3/15/2013

Santa Clara, California (PRWEB) March 15, 2013

The world's leading, fully integrated, independent laboratory network, providing high value expert analytical and testing services to a wide range of industries and end users, is pleased to announce the appointment of Aram Sarkissian as the new General Manager of EAG’s Release-To-Production (RTP) division.

Mr. Sarkissian is a seasoned leader with two decades of customer-facing experience in the semiconductor services market. He joined EAG in 2007 as part of the acquisition of Accurel, where he served in a variety of roles with increasing responsibilities in Engineering, Sales & Marketing, and management to help build the business into a leading lab services provider. Upon joining EAG, Mr. Sarkissian was instrumental in the integration of Accurel and moved into a VP of Sales role at EAG where he continued to help grow and shape the RTP business division and establish it as a world class semiconductor services organization. Mr. Sarkissian holds a BS in Electrical Engineering and Computer Science from the University of California at Berkeley.

“I am honored to accept the appointment as General Manager of the RTP Division and am extremely enthusiastic about our prospects looking forward. The services provided by our Division are second to none.” remarked Mr. Sarkissian.

Harry Davoody, CEO of EAG, stated “Aram has a deep understanding of the service requirements and the high bar set by the semiconductor industry. The credibility he has earned with our customers will serve him well in his new role.”

About Evans Analytical Group
EAG is the world's leading, fully integrated, independent laboratory network. EA
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
2. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
3. Verenium Announces Preliminary Financial Results For Fiscal 2012
4. Probiotic Action Announces Probiotics Lead the Digestive Health Market
5. Annual Conference about Technology Solutions for People with Disabilities Announces Program
6. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
7. Research and Markets Announces the Release of Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities
8. Z Trim Holdings Announces Conclusion of Successful Warrant Exercise Program: Raises $2.195 Million
9. EAG Announces General Manager of Environmental Fate, Chemistry and Ecotoxicology (EFCE) Division
10. Pittcon 2013 Announces Exposition Highlights
11. Real Time Genomics Announces Formation of its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- Working in collaboration with the National Amyloidosis ... , Richmond Pharmacology is the first centre worldwide to ... an investigational RNAi therapeutic being developed for the treatment of ... heart. Read press release ... St Georges University of London , Richmond ...
(Date:3/27/2015)... 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , today ... ended December 31, 2014.  The Company ... per share, for the three months ended December 31, ...
(Date:3/26/2015)... N.J., March 26, 2015  Roka Bioscience, Inc. ... focused on providing advanced testing solutions for the ... results for the three months and full year ... 2014 Financial Results:Revenue for the quarter ended December ... for the fourth quarter of 2013 and $1.5 ...
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - SQI Diagnostics ... announced that after dealing with certain matters, including the ... shareholders held on March 26, 2015 (the "Meeting") was ... April 8, 2015 at 11:00 a.m. ( Toronto ... has been changed from that previous disclosed. The Meeting ...
Breaking Biology Technology:CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7SQI Diagnostics Inc. Announces Adjournment of Meeting 2
... Now Has Four Phase 2 Trials Underway, MONTVALE, ... ) has dosed the first patient in a 160-patient ... failure. BREAK (Beginning a,Randomized Evaluation of the A.G.E. [Advanced ... a randomized,double-blind, placebo controlled study to assess the effect ...
... NEW YORK, May 13 NeoStem, Inc. (Amex: ... and long-term,storage of adult stem cells for future medical ... a new stem cell collection center in Coral,Gables, Florida, ... NeoStem,s Chairman and Chief Executive Officer,commented: "Securing the Florida ...
... 13 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: ... company focused on,endocrine therapy and oncology, today ... 2 study of subcutaneously,administered LHRH antagonist cetrorelix ... has been accepted for publication in an,upcoming ...
Cached Biology Technology:Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 2Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 3Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 4NeoStem to Expand Stem Cell Collection Center Network to Florida 2NeoStem to Expand Stem Cell Collection Center Network to Florida 3AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 2AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 3AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 4AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 5AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 6
(Date:3/17/2015)... DIEGO , March 17, 2015 ... emotion analytics software, today announced general availability of ... web service for the analysis of facial expressions. ... experience advertising, media content, products and services. It ... attention, engagement and sentiment - as derived from ...
(Date:3/12/2015)... BERLIN , March 12, 2015 ... IAM, a standardized identity and access management (IAM) ... reliable implementation schedule. With Beta System,s new IAM ... and best practices gleaned from multiple IAM implementations ... includes the software as well as any necessary ...
(Date:3/10/2015)... , March 10, 2015 ... "Personalized Medicine in Human Space Flight" ... Thomas J. Goodwin , Ph.D. was recently featured ... the past two years. Specifically, "Personalized Medicine ... downloaded scientific papers published in 2013 and 2014 from ...
Breaking Biology News(10 mins):New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... Tobacco smoking by pregnant women has long been ... adverse effects on the development of a fetus. ... outcomes, including low birth weight, sudden infant death syndrome, ... and nicotine use in offspring. Despite this extensive literature, ...
... to help fertilize crops, it is vital to understand the ... Burkholderia , for example, includes dangerous disease-causing pathogens one ... but also many species that are safe and important ... good and evil be told apart? Yes, UCLA life scientists ...
... - Scientists at A*STAR,s Institute of Molecular and Cell ... sequenced and analysed the genome of the elephant shark. ... human and other vertebrate genomes revealed why the skeleton ... The findings carry potential implications for human bone disease ...
Cached Biology News:Maternal stress hormones and maternal smoking increase daughter's risk of nicotine dependence 2UCLA life scientists, colleagues differentiate microbial good and evil 2UCLA life scientists, colleagues differentiate microbial good and evil 3Elephant shark genome provides new insights into bone formation and adaptive immunity in humans 2Elephant shark genome provides new insights into bone formation and adaptive immunity in humans 3
Yields DNA greater than 50 kb in length from yeast, fungi, Gram neg. and Gram pos. bacteria...
Mouse monoclonal [1Q17] to TGE Virus peplomer ( Abpromise for all tested applications)....
Jak3 Antibody Ship: Hot Store: -20 C...
14-3-3 tau Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: